Texas Oncology made significant contributions at this year's ASCO Quality Care Symposium, where we presented 12 groundbreaking studies advancing oncology care. We were also honored to have our Executive Vice President Debra Patt, M.D., PhD, MBA, participate in an insightful podium presentation on "Complexities of the Pharmaceutical Supply Chain: What Everyone in Oncology Should Know." Our posters included: ▪ Dedicated OAM Oncology Navigation program to improve access to medication education, ePRO enrollment, and physician treatment plan completion adherence. ▪ Selinexor dose optimization: A retrospective analysis. ▪ Effect of a virtual oncology telemedicine advanced practice provider clinic on patient financial burden and access to care disparities in patients with new benign hematologic cancer. ▪ Oncology care model cost data for breast, lung, and multiple myeloma: Influence of outpatient rehabilitation therapy services. ▪ Use of ambient AI scribing: Impact on physician administrative burden and patient care. ▪ Genetic evaluations and testing results for hereditary colon and uterine cancer syndrome in a community oncology setting. ▪ Oncology nurses’ assessment of providing equitable care for patients with developmental disabilities. ▪ The Languages of Love Support Group: Exploring quality of life and relationship satisfaction among couples experiencing cancer. ▪ Process improvements related to new patient scheduling. ▪ The impact of oral oncology drugs in the era of value-based care. ▪ Impact of a mortality prediction tool on end-of-life (EOL) quality measures. ▪ Virtual addressing reality: Development of a virtual social work program to address health-related social needs. We deeply appreciate our dedicated team members who represented Texas Oncology and contributed to the symposium's success. Your commitment to advancing cancer care and improving patient outcomes continues to inspire and drive our mission forward. #HealthcareInnovation #ASCOQLTY24 #TexasOncology
-
+1